Analyst Rating Flashback: Myriad Genetics Up 6.4% Since Downgraded 7 Days Ago (MYGN)

One week ago Myriad Genetics (NASDAQ:MYGN) was downgraded from Overweight to Equal Weight at Barclays Capital. The shares closed at $20.96, or 6.4% over the $19.70 price of one...